TAKEDA ONCOLOGY Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for TAKEDA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the TAKEDA ONCOLOGY trademark a serial number of 86476462. The federal status of this trademark filing is REGISTERED as of Tuesday, April 3, 2018. This trademark is owned by Takeda Pharmaceutical Company Limited. The TAKEDA ONCOLOGY trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Providing live and on-line classes and seminars in the field of cancer treatment

Pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services
takeda oncology

General Information

Serial Number86476462
Word MarkTAKEDA ONCOLOGY
Filing DateWednesday, December 10, 2014
Status700 - REGISTERED
Status DateTuesday, April 3, 2018
Registration Number5438550
Registration DateTuesday, April 3, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 30, 2015

Trademark Statements

Goods and ServicesProviding live and on-line classes and seminars in the field of cancer treatment
Description of MarkThe mark consists of the word "TAKEDA" in stylized red lettering, appearing inside of two red intersecting arcs, the lower arc with a straight line on the bottom and the higher arc being thicker in size and with two sides extending over the lower arc; below the straight line of the lower arc appears the word "ONCOLOGY" in black stylized lettering. The white in the mark represents background or transparency and is not claimed as a feature of the mark.
Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"ONCOLOGY"
Goods and ServicesPharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, December 15, 2014
Primary Code041
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateWednesday, April 1, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 15, 2014
Primary Code042
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateWednesday, April 1, 2015

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, March 1, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 28, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 20, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 23, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 23, 2018FINAL REFUSAL E-MAILED
Tuesday, January 23, 2018SU - FINAL REFUSAL - WRITTEN
Friday, January 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 26, 2017NON-FINAL ACTION E-MAILED
Saturday, August 26, 2017SU - NON-FINAL ACTION - WRITTEN
Saturday, August 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 11, 2017USE AMENDMENT FILED
Tuesday, July 11, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2017SOU EXTENSION 3 GRANTED
Monday, February 27, 2017SOU EXTENSION 3 FILED
Monday, February 27, 2017TEAS EXTENSION RECEIVED
Saturday, September 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 2, 2016SOU EXTENSION 2 GRANTED
Monday, August 8, 2016SOU EXTENSION 2 FILED
Wednesday, August 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2016TEAS EXTENSION RECEIVED
Saturday, January 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2016SOU EXTENSION 1 GRANTED
Thursday, January 21, 2016SOU EXTENSION 1 FILED
Thursday, January 21, 2016TEAS EXTENSION RECEIVED
Tuesday, August 25, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 26, 2015ASSIGNED TO LIE
Wednesday, April 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 8, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 8, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 24, 2015ASSIGNED TO EXAMINER
Tuesday, December 16, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 13, 2014NEW APPLICATION ENTERED

Related Keywords

oncology takeda pharmaceutical providing development field research pharmaceuticals information clinical trials services